Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Iron-Dependent Biomarkers of Malignant Glioma (WHO Grade IV) Progression

NCT07447531 is registered in ClinicalTrials.gov with John M. Buatti as lead sponsor.

NCT NCT07447531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07447531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Iron-Dependent Biomarkers of Malignant Glioma (WHO Grade IV) Progression
Lead sponsor
John M. Buatti
Phase
Not applicable
Overall status
Recruiting
Start date
October 3, 2025
Completion date
October 6, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant glioma